Regeneron-Sanofi Eczema Drug Shows Improvements In Itchy Inflammatory Skin Disease
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (NASDAQ:SNY) presented detailed results from the second of two Phase 3 trials (PRIME) evaluating…
Gilead’s Trodelvy Shows Improved Overall Survival In Pretreated Breast Cancer Settings
Gilead Sciences Inc (NASDAQ:GILD) announced the overall survival (OS) results from the Phase 3 TROPiCS-02 study of Trodelvy (sacituzumab govitecan-hziy) versus…
2 High-Yielding Dividend ETFs That May Help Diversify Your Investment Strategy
Hunting for the perfect dividend stocks for your portfolio can be a challenging aspect of diversification. An easy way to mitigate these issues is by purchasing an exchange-traded fund (ETF) that invests in high-yielding stocks that fit your strategy.
The pros of investing in a dividend ETF:
Alnylam Shares Detailed Patisiran Data From Rare Disease Study
Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) announced positive results from the APOLLO-B Phase 3 study of patisiran for transthyretin-mediated (ATTR) amyloidosis with cardiomyopathy.
Regeneron Gains As New Data Favors Higher Dose Of Flagship Eye Disease Drug
Regeneron Pharmaceuticals Inc’s (NASDAQ:REGN) two pivotal trials evaluating aflibercept 8 mg with 12- and 16-week dosing regimens met the primary…
Apple Introduces Apple Watch Series 8, Watch SE And New Ultra Edition
Apple Inc (NASDAQ: AAPL) hosted its fall hardware event today and introduced the new Watch Series 8 wearables, stating the 'best apple watch series lineup so far".
Zealand Pharma, Novo Nordisk Ink Licensing Pact For Drug To Lower Blood Sugar Levels
Zealand Pharma A/S (NASDAQ:ZEAL) has entered into a global license and development agreement with Novo Nordisk A/S (NYSE:NVO) to commercialize Zegalogue (dasiglucagon) for…
Here’s How to Own 2 Dividend Stocks Mets Owner Steve Cohen and Carolina Panthers Owner David Tepper Have In Common
According to the Pro Football Network, David Tepper, the owner of the Carolina Panthers and hedge fund manager for Appaloosa Management is the third-richest NFL owner, with an estimated net worth of roughly $16.7 billion.
European Commission Says No To Illumina-Grail Deal – What’s Next?
The European Commission has prohibited Illumina Inc’s (NASDAQ:ILMN) acquisition of GRAIL. The company is reviewing the Commission’s order and intends to…